Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain

European Journal of Neuroscience

Volumn 31, Issue 8, 2010, Pages 1414-1422

  Sagar, Devi Rani ^a   Jhaveri, Maulik D ^a   Richardson, Denise ^a   Gray, Roy A ^b   De Lago, Eva ^c   Fernández Ruiz, Javier ^c   Barrett, David A ^a   Kendall, David A ^a   Chapman, Victoria ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cannabinoid; CB2 receptor; Dorsal horn; Electrophysiology; Rat; UCM707

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ENDOCANNABINOID; N (3 FURYLMETHYL)ARACHIDONAMIDE; VANILLOID RECEPTOR 1; AMIDE; ARACHIDONIC ACID DERIVATIVE; BORNANE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; FURAN DERIVATIVE; N-(3-FURYLMETHYL)EICOSA-5,8,11,14-TETRAENAMIDE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EVOKED RESPONSE; FACILITATION; MALE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RECEPTOR BLOCKING; SHAM PROCEDURE; SPINAL CORD NERVE CELL; ANESTHESIA; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; EVOKED SOMATOSENSORY RESPONSE; METABOLISM; MICROELECTRODE; NERVE CELL; NEURALGIA; SPINAL CORD; SPRAGUE DAWLEY RAT; STIMULATION;

ANESTHESIA; ANIMALS; ARACHIDONIC ACIDS; BORNANES; CANNABINOID RECEPTOR MODULATORS; CENTRAL NERVOUS SYSTEM AGENTS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; EVOKED POTENTIALS, SOMATOSENSORY; FURANS; MALE; MICROELECTRODES; NEURALGIA; NEURONS; PHYSICAL STIMULATION; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SPINAL CORD; TRPV CATION CHANNELS;

EID: 77951175698     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07162.x     Document Type: Article

References (40)

1. Azad, S.C., Kurz, J., Marsicano, G., Lutz, B., Zieglgansberger, W. Rammes, G. (2008) Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learn. Mem., 15, 143 152.
2. Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S. Reggiani, A. (2006) CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci., 23, 1530 1538.
3. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. Yaksh, T.L. (1994) Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods, 53, 55 63.
4. Chapman, V. (1999) The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. Br. J. Pharmacol., 127, 1765 1767.
5. Chapman, V., Suzuki, R. Dickenson, A.H. (1998) Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6. J. Physiol., 507 (Pt 3) 881-894.
6. Costa, B., Siniscalco, D., Trovato, A.E., Comelli, F., Sotgiu, M.L., Colleoni, M., Maione, S., Rossi, F. Giagnoni, G. (2006) AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br. J. Pharmacol., 148, 1022 1032.
7. De Petrocellis, L. Di Marzo, V. (2009) Role of endocannabinoids and endovanilloids in Ca2+ signalling. Cell Calcium, 45, 611 624.
8. Elmes, S.J., Jhaveri, M.D., Smart, D., Kendall, D.A. Chapman, V. (2004) Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur. J. Neurosci., 20, 2311 2320.
9. Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L. James, I. (2001) The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91 100.
10. Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D. Hipkin, R.W. (2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol., 57, 1045 1050.
11. Guasti, L., Richardson, D., Jhaveri, M., Eldeeb, K., Barrett, D., Elphick, M.R., Alexander, S.P., Kendall, D., Michael, G.J. Chapman, V. (2009) Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol. Pain, 5, 35.
12. Hohmann, A.G., Tsou, K. Walker, J.M. (1998) Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci. Lett., 257, 119 122.
13. Hwang, J.H. Yaksh, T.L. (1997) The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain, 70, 15 22.
14. Ibrahim, M.M., Deng, H., Zvonok, A., Cockayne, D.A., Kwan, J., Mata, H.P., Vanderah, T.W., Lai, J., Porreca, F., Makriyannis, A. Malan, T.P. Jr. (2003) Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl Acad. Sci. USA, 100, 10529 10533.
15. Ishikawa, T., Marsala, M., Sakabe, T. Yaksh, T.L. (2000) Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist. Neuroscience, 95, 781 786.
16. Jhaveri, M.D., Richardson, D., Kendall, D.A., Barrett, D.A. Chapman, V. (2006) Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci., 26, 13318 13327.
17. Kaczocha, M., Hermann, A., Glaser, S.T., Bojesen, I.N. Deutsch, D.G. (2006) Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J. Biol. Chem., 281, 9066 9075.
18. Kim, S.H. Chung, J.M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355 363.
19. La Rana, G., Russo, R., Campolongo, P., Bortolato, M., Mangieri, R.A., Cuomo, V., Iacono, A., Raso, G.M., Meli, R., Piomelli, D. Calignano, A. (2006) Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. J. Pharmacol. Exp. Ther., 317, 1365 1371.
20. de Lago, E., Fernandez-Ruiz, J., Ortega-Gutierrez, S., Viso, A., Lopez-Rodriguez, M.L. Ramos, J.A. (2002) UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. Eur. J. Pharmacol., 449, 99 103.
21. de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega-Gutierrez, S., Fernandez-Ruiz, J. Di Marzo, V. (2005) Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochem. Pharmacol., 70, 446 452.
22. Lopez-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S., Lastres-Becker, I., Gonzalez, S., Fernandez-Ruiz, J. Ramos, J.A. (2001) Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J. Med. Chem., 44, 4505 4508.
23. Lopez-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S., Fowler, C.J., Tiger, G., de Lago, E., Fernandez-Ruiz, J. Ramos, J.A. (2003) Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J. Med. Chem., 46, 1512 1522.
24. McGaraughty, S., Chu, K.L., Dart, M.J., Yao, B.B. Meyer, M.D. (2009) A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors. Neuroscience, 158, 1652 1661.
25. Meng, I.D., Manning, B.H., Martin, W.J. Fields, H.L. (1998) An analgesia circuit activated by cannabinoids. Nature, 395, 381 383.
26. Milligan, E.D. Watkins, L.R. (2009) Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci., 10, 23 36.
27. Mitrirattanakul, S., Ramakul, N., Guerrero, A.V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K.F. Spigelman, I. (2006) Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain, 126, 102 114.
28. Ortega-Gutierrez, S., Molina-Holgado, E., Arevalo-Martin, A., Correa, F., Viso, A., Lopez-Rodriguez, M.L., Di Marzo, V. Guaza, C. (2005a) Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis. FASEB J., 19, 1338 1340. (Pubitemid 41113742)
29. Ortega-Gutierrez, S., Molina-Holgado, E. Guaza, C. (2005b) Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia, 52, 163 168.
30. Pernia-Andrade, A.J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T.F., Watanabe, M., Filitz, J., Koppert, W., Schuttler, J., Ji, G., Neugebauer, V., Marsicano, G., Lutz, B., Vanegas, H. Zeilhofer, H.U. (2009) Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science (New York, NY), 325, 760 764.
31. Petrosino, S., Palazzo, E., de Novellis, V., Bisogno, T., Rossi, F., Maione, S. Di Marzo, V. (2007) Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology, 52, 415 422.
32. Richardson, J.D., Aanonsen, L. Hargreaves, K.M. (1997) SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol., 319, R3 R4.
33. Richardson, D., Ortori, C.A., Chapman, V., Kendall, D.A. Barrett, D.A. (2007) Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem., 360, 216 226.
34. Romero-Sandoval, A., Nutile-McMenemy, N. DeLeo, J.A. (2008) Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology, 108, 722 734.
35. Sagar, D.R., Kelly, S., Millns, P.J., O'Shaughnessey, C.T., Kendall, D.A. Chapman, V. (2005) Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur. J. Neurosci., 22, 371 379.
36. Smart, D., Gunthorpe, M.J., Jerman, J.C., Nasir, S., Gray, J., Muir, A.I., Chambers, J.K., Randall, A.D. Davis, J.B. (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227 230.
37. Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S. Winter, J. (2005) Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience, 135, 235 245.
38. Yamamoto, W., Mikami, T. Iwamura, H. (2008) Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain. Eur. J. Pharmacol., 583, 56 61.
39. Zhang, J., Hoffert, C., Vu, H.K., Groblewski, T., Ahmad, S. O'Donnell, D. (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci., 17, 2750 2754.
40. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D. Hogestatt, E.D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452 457.